In patients with GC and CRC, the proportions of TMB-high tumors were significantly higher in the ERBB2-mutant group than in the ERBB2-wild-type group (p < 0.05), whereas, in patients with EAC, no significant difference was found between the groups (p = 0.11). The gene discussed is ERBB2; the disease is gastric cancer.